Systematic review of single-port vs. multi-port surgery for rectal cancer

The aim of the current systematic review was to compare the short-term clinical and oncological outcomes of single-port surgery (SPS) to multi-port surgery (MPS) for rectal cancer in MEDLINE, PubMed and Cochrane Library from January 2010 to December 2018. A total of 5 clinical controlled studies com...

Full description

Saved in:
Bibliographic Details
Published in:Molecular and clinical oncology 2021-02, Vol.14 (2), p.24-24, Article 24
Main Authors: Tei, Mitsuyoshi, Sueda, Toshinori, Matsumura, Tae, Furukawa, Haruna, Koga, Chikato, Wakasugi, Masaki, Miyagaki, Hiromichi, Kawabata, Ryohei, Tsujie, Masanori, Hasegawa, Junichi
Format: Article
Language:English
Subjects:
Abdominal surgery
Body mass index
Cancer
Colorectal cancer
Comparative analysis
Hospitals
Laparoscopy
Lymphatic system
Morbidity
Mortality
Oncology
Oncology, Experimental
Pain
Patients
Postoperative period
Surgical outcomes
Systematic review
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The aim of the current systematic review was to compare the short-term clinical and oncological outcomes of single-port surgery (SPS) to multi-port surgery (MPS) for rectal cancer in MEDLINE, PubMed and Cochrane Library from January 2010 to December 2018. A total of 5 clinical controlled studies composed one randomized pilot study and four non-randomized studies with a total of 461 patients were analyzed after a systematic review. A total of 125 patients (27.1%) underwent SPS and 336 patients (72.9%) underwent MPS for rectal cancer. The rate of conversion to open surgery was lower in the SPS group compared with the MPS group (0.8 vs. 5.4%, respectively). A total of 16.8% of patients in the SPS group required an additional port to complete the operation. The morbidity rate was lower in the SPS group compared with the MPS group (28.0 vs. 39.0%, respectively). The other short-term clinical outcomes were similar in both groups. The R0 resection rate was 99.0% in the SPS group and 98.7% in the MPS group. The oncological clearance was satisfactory and similar in both groups. The current study concluded that SPS can be performed safely and provide satisfactory oncological outcomes in patients with rectal cancer. However, further studies are required to determine the role of SPS in the long-term clinical and oncological outcomes.
ISSN:2049-9450
2049-9469
DOI:10.3892/mco.2020.2186